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gastrointestinal microbiota of humans, animals and other species. CNTs and clostridia have undergone a separate evolution, with clostridia forming an ancient class of bacteria with a complex phylogenetic history, and CNTs emerging more recently in a subset of clostridial lineages. BoNT genes are found in the species C. botulinum, C. argentinense, C. sporogenes, C. baratii and C. butyricum, although the species C. botulinum is polyphyletic, and not all strains of these species are neurotoxigenic (Peck 2009; Weigand et al. 2015; Williamson et al. 2016) . Consistent with the mobility evidenced by their scattered phyletic distribution in Clostridium, bont genes can be encoded on the chromosome, plasmids or phages. They are found within characteristic gene clusters, typically flanked by genes that enhance mobility, such as transposases and insertion sequence elements (Dineen, Bradshaw and Johnson 2003; Sebaihia et al. 2007; Skarin and Segerman 2011; Carter and Peck 2015; Williamson et al. 2016) . TeNT is encoded on a virulence plasmid of C. tetani of variable composition, but all contain the tetanus regulator tetR and a collagenase gene (Brüggemann et al. 2015) .
BoNTs are the most potent known toxins, and have evolved a unique and complex mechanism of toxicity. BoNT is composed of an N-terminal zinc metalloprotease domain (the light chain) which is disulfide linked to a heavy chain composed of a translocation domain and two binding domains. The mechanism of action involves entry into a host (e.g. mammal, bird or fish) through a wound or absorption through the gut, circulation of the toxin through the bloodstream and lymphatic system, binding to receptors on the presynaptic membrane of neuromuscular junctions, delivery into neurons by receptor-mediated endocytosis, pH-mediated translocation into the cytoplasm and cleavage of intracellular SNARE proteins, thereby inhibiting neurotransmitter release and ultimately leading to flaccid paralysis.
Aiding BoNTs are additional neurotoxin-associated proteins (NAPs) which are encoded within bont gene clusters. These include an immediate downstream non-toxic paralog (non-toxic non-hemagglutinin, or NTNH), as well as either hemagglutinin (ha) or orfX genes, dividing the gene clusters into two main types. Strains may possess one or more toxin gene clusters, which may be the same or different toxin cluster types. NTNH and the three HA proteins form complexes that associate with BoNT, and these complexes protect the toxin in the gut environment and mediate attachment to the gut epithelium via E-cadherin (Lee et al. 2014) . There is some evidence for additional roles for the 'nontoxic' NAP complex (Miyashita et al. 2016) .
WHERE DID BoNTs COME FROM?
Although there is considerable knowledge on the BoNT mode of action (see Montecucco 2014 and Pirazzini et al. 2017 for recent reviews), the physiological benefit of bont genes to their bacterial hosts is less clear. The BoNT protein does not appear to provide an obvious fitness benefit to its producer, nor is it essential for survival (DasGupta 2006; Montecucco and Rasotto 2015) . With this in mind, how and why did such a toxin evolve? This fundamental question about the origins of botulism and tetanus has been a mystery since these toxins were first discovered over a century ago. The origins of BoNTs have been elusive for several reasons, but the most important is that, prior to a few years ago, there were no known evolutionary relationships between BoNTs and other protein families that could shed light on their ancestry.
In a 2006 paper, B.R. DasGupta speculated on the evolutionary origins of these toxins, suggesting that their ancestors were not found within the genus Clostridium, but instead were ultimately derived from viral polyproteins. This hypothesis was based on several pieces of evidence, including the independent action of different domains within the toxin, the observation that viral metalloproteases also known to cleave cellular proteins, and the conceivable notion of viruses as quintessential vectors for the transfer of foreign DNA into a host genome. It was also suggested that there is no reason that such toxins should necessarily be limited to cleaving SNARE proteins from vertebrates, and that the toxin family may be far more ancient.
Roughly a decade later, work by Mansfield, Adams and Doxey (2015) provided evidence for DasGupta's hypothesis by identifying a distant, but clearly related, homolog of BoNTs in the genome outside of the Clostridium genus. This protein, encoded within the genome of an organism called Weissella oryzae SG25, possesses all the properties that are expected of a divergent homolog: remote sequence similarity but with detectable homology, conserved domain architecture, and conserved active sites and functional motifs (Mansfield, Adams and Doxey 2015) . Follow-up work by Zornetta et al. (2016) then confirmed the W. oryzae BoNT-like toxin to possess similar activity to BoNTs by cleaving VAMP2, but interestingly, at a unique W-W bond unlike any other BoNTs. Whether this protein is truly a neurotoxin, however, remains unknown, as do its preferred host or even cell type. Why such a toxin exists within Weissella, a lactic-acid fermenting species isolated from the grains of Japanese rice, is also unclear. Regardless of these uncertainties, the Weissella homolog provided an indication that there may exist a larger family of divergent BoNT-like toxins in non-clostridial species that could provide insights into their ancestry and evolution.
Following the discovery of the W. oryzae bont-like gene, numerous additional BoNT-like toxins have now been identified by genomic data mining methods. First, a novel BoNT-like protein in C. botulinum str. 111, nominally named BoNT/X, was shown to result in botulism-like flaccid paralysis when injected into mice . This activity was caused by catalytic cleavage of VAMP, a canonical BoNT target, which was cleaved at a novel site. Furthermore, Zhang et al. (2018) recently identified and characterized a BoNT-like toxin in Enterococcus faecium str. DIV0629. This Enterococcus BoNT-like gene, 'BoNT/En', possesses all the hallmarks of a BoNT: the presence of all BoNT domains and key functional motifs, and is located within an orfX-like gene cluster. Injection of the full-length BoNT/En protein into mice did not result in paralysis, but injection of the BoNT/En light chain ligated to the BoNT/A heavy chain resulted in flaccid paralysis. Thus, BoNT/En is unable to specifically bind and enter mouse neurons, but is capable of cleaving neuron substrates. Indeed, expression of the toxin in cultured neurons reveals surprisingly broad protease specificity, cleaving VAMP2 and SNAP25 at unique sites, as well as several additional SNARE proteins (i.e. SNAP23) with lower efficiency. Like Weissella toxin, BoNT/En appears to have been laterally transferred into this strain of Enterococcus from an unknown source, and so its functional role in Enterococcus is unclear. Independently, the BoNT/En gene cluster has been identified bioinformatically by two other groups: Williamson et al. (2017) and Brunt et al. (2018) who proposed the name eBoNT/J for this toxin. Mansfield et al. (2017) and Wentz et al. (2017) discovered a highly divergent group of BoNT-like toxins in the genome of Chryseobacterium piperi str. CTM, as well as additional BoNT-like genes in other Actinobacteria. One of the predicted C. piperi BoNT-like toxins induced necrotic cell death in human kidney cells, but was not found to cleave common SNARE substrates of BoNTs. Ultimately, the C. piperi toxins represent a distantly related group of toxins that share partial similarities to BoNTs, and provide a model for understanding the unique molecular changes that have occurred leading up to the BoNT lineage, particularly with respect to the evolution of the BoNT-LC . Additionally, it is important to note that, to date, the aforementioned BoNT-like proteins have only been examined biochemically in isolation from their host organism and biological context. Considerable work is needed to characterize the environmental conditions in which BoNT-like proteins are produced by their host organisms, the degree to which they are active, and their potential host and substrate specificity.
Lastly, fragments of bont-like genes have been detected in environmental metagenomic samples, including the termite gut (Doxey, Mansfield and Montecucco 2018) . Because these are only fragments and have not been assembled into larger contigs, it is unclear whether they are derived from full-length homologs of BoNTs. Further sequencing and analysis will be necessary to confirm whether these represent true BoNT homologs, and elucidate their relationship to other BoNTs.
In this work, we provide an updated phylogenetic analysis that includes bona fide BoNTs and recent, computationally identified bont-like genes from non-clostridial species. Using the tree as an evolutionary framework, we discuss key questions regarding the evolution of BoNTs such as: What features emerged specifically in the lineage leading to BoNTs? How has host and substrate specificity evolved? What was the function of the BoNT ancestor? How have serotypes diverged? And what was the function of the BoNT's evolutionary precursors? Finally, we speculate on the possible ecological roles of BoNTs for their natural hosts, which may also shed light on the functions of other BoNT-like genes that will undoubtedly continue to be identified in future genomes and metagenomes.
A phylogeny of BoNTs and BoNT-like genes
Figure 1 reveals an updated phylogenetic tree of BoNTs and BoNT-like proteins. Although construction of an accurate phylogeny is complicated by recombination and lateral gene transfer events, this is nonetheless a useful representation of relationships between the BoNTs. Mapped onto the tree are various conserved and variable features that provide insights into BoNT evolution. By including recently identified divergent BoNT homologs (e.g. Weissella toxin), it is possible to root the BoNT phylogeny and infer evolutionary directionality in the tree, as well as estimating a possible order in which various clades emerged.
The tree is largely consistent with previous phylogenetic analyses (Collins and East 1998; Brunt et al. 2018) , dividing the family into serotypes. BoNT/E and F form one major group, which forms a larger clade with BoNT/A. This clade is sister to a clade containing B, G and TeNT. The clade containing C and D appears to have diverged earlier in the history of the family. Finally, BoNT/En and BoNT/X cluster together along an early diverging lineage that forms a sister group to the other BoNTs. Beyond BoNT/X and BoNT/En is the Weissella toxin which diverged before the lineage leading to all BoNTs, and may even predate the origin of the BoNT clade. Finally, the Chryseobacterium toxin represents a divergent sister lineage to BoNTs and the Weissella toxin, outgrouping the entire tree. While it shares detectable homology with BoNTs, it also lacks numerous BoNT features, and is thus better considered a distant homolog.
Origin of TeNT and its surprising lack of diversity
In most respects, TeNT is similar to BoNTs. All BoNT domains are present in TeNT, demonstrating sequence homology across the length of the molecule, sharing an average of 36% identity with BoNT serotypes. Both TeNT and BoNTs function by binding and entering neurons and cleaving SNAREs; further, TeNT cleaves VAMP2 at the same site as BoNT/B (Montecucco and Schiavo 1994) . The most important difference is the location of this cleavage event: BoNTs cleave SNAREs within cholinergic nerve terminals, while TeNTs undergo retrograde axonal transport and target inhibitory neurons in the central nervous system (Pellizzari et al. 1999) . This is the cause of pathological differences between botulism, characterized by flaccid paralysis, and tetanus, which is characterized by uncontrollable spasms. The TeNT gene is found only in the species C. tetani, where it is encoded on a plasmid.
According to the tree, TeNT is not a sister lineage to BoNTs, nor is it even the most divergent member of the BoNTs (Fig. 1) . Rather, TeNT is nested within the BoNT tree as an early diverging member of the B + G clade. TeNT has a number of unique properties, the most obvious of which is the lack of NAPs. TeNT is not found in BoNT-like gene clusters, and is not flanked by ntnh or ha/orfX genes. Based on the phylogeny, the most parsimonious explanation is that the TeNT lineage has lost these NAPs rather than multiple individual gain events. The secondary loss of NAPs in the TeNT lineage suggests that these proteins did not play an important role for the TeNT ancestor. Perhaps this reflects the differences in physiological environment between TeNT, which is produced in wounds, and BoNT, where NAPs may confer greater specialization for the gut environment. Overall, TeNT is most likely an 'evolutionary outlier' in the history of the BoNT family, having lost ancestral traits while gaining novel functionality, and illustrates the potential for BoNT functional divergence.
Another anomalous characteristic in the TeNT lineage is the relative lack of sequence diversity among TeNT genes compared to the various BoNT serotypes. Comparative genomic analysis of C. tetani strains has confirmed this limited variation, and shown that despite variation elsewhere in the C. tetani genome, the tetanus toxin exhibits very low variation (>98% identity) (Brüggemann et al. 2015; Cohen et al. 2017) . Despite this, it is notable that there is an increased proportion of variable sites in the binding domains, particularly in the HC C domain, which could hint at positive selection for adaptive shifts in binding (Kumar and Singh 2016; Adams et al. 2017) .
Does the lack of TeNT sequence variation simply reflect a lack of sampling, where known TeNTs are simply a subset of a larger repertoire of TeNT-like sequences in the environment, or are there other functional or evolutionary constraints that limit TeNT sequence variation? The answer to these questions is still unclear.
Evolutionary diversification within the BoNT family
Given recently sequenced genomes of Clostridia (Williamson et al. 2016 ) and the identification of BoNT-like toxins by genomic data mining (Doxey, Mansfield and Montecucco 2018) , there has been considerable diversification within the BoNT tree. How and why have the different serotype lineages emerged and diverged from one another? Related to this question, why are the branches between serotypes so deep-between-serotype % identities may drop as low as 30%-with comparatively minimal variation within serotypes?
The structure of the BoNT tree is suggestive of an ancient adaptive radiation followed by extensive anagenesis in each lineage. One possibility that could explain this phenomenon is that different serotypes have been produced by host-pathogen co-evolutionary diversification (Althoff, Segraves and Johnson 2014; Kumar and Singh 2016) . Co-evolution between host receptors and virulence factors is well established and is known to drive accelerated evolution and diversification (Woolhouse et al. 2002; Ebert 2008; Paterson et al. 2010; Dybdahl, Jenkins and Nuismer 2014; Masri et al. 2015) . Several lines of evidence support the idea of BoNT-host coevolutionary diversification. Different serotypes appear to exhibit host-specific adaptations: human botulism is mostly caused by serotypes A, B, E and rarely F; avian botulism is mostly caused by types C/D and E (Takeda et al. 2005; Yule et al. 2006; Smith et al. 2007; Hannett et al. 2011) . Recent work suggests that even subtle changes in BoNT may result in an alteration or refinement of host specificity; for instance, under laboratory conditions human neuron sensitivity to BoNT/B was increased significantly by the mutation of a single residue in the binding domains (Tao et al. 2017) . While the extant serotype lineages may be the outcome of long-term host-pathogen coevolution, their initial diversification may have arisen through these types of minimal host specificity-altering amino acid substitutions.
Co-evolution has potentially occurred not only between BoNTs and their receptors but also between BoNTs and their SNARE substrates (Kumar, Chang and Singh 2015) . It has been suggested that sequence variation across vertebrate VAMP1 reflects a selective pressure to evade cleavage by BoNT (Peng et al. 2014) . In humans, however, BoNT cleavage sites are highly conserved, suggesting little to no selective pressure from BoNT (Carle et al. 2017) .
Repeated evolution of substrate specificity in the history of BoNT
BoNTs have undergone several shifts and/or refinements in substrate specificity during the course of their evolution (Fig. 1) . The vesicle-associated SNARE VAMP, or synaptobrevin, is cleaved by serotypes B, D, F, G, X, TeNT, En and the Weissella BoNT-like protein, and the outer membrane-associated SNAP25 is cleaved by A, C, C/D and En (see Pirazzini et al. 2017 for a comprehensive review of cleavage sites). BoNT serotypes typically cleave one of these SNAREs at a specific site, with the exceptions of BoNT/C, which also cleaves syntaxin, and BoNT/En, which cleaves both VAMP and SNAP25. BoNT/F subtypes are capable of cleaving VAMP2, but F5 and F5A cleave at a unique site.
The substrate specificity of BoNTs is diverse and has a scattered distribution on the phylogenetic tree ( Fig. 1) , which may reflect inherent evolutionary plasticity in substrate recognition. By evolutionary parsimony, there are at least three substrate shifts that must have occurred in the evolution of BoNTs, with the BoNT ancestor most likely cleaving VAMP2 (which is also consistent with the recently determined specificities of divergent BoNT-like toxins). In this model, A, C and E have independently shifted toward a SNAP25 specificity from an ancestor possessing a VAMP2 specificity. This apparent parallel evolution toward SNAP25 specificity suggests that each of these lineages has separately adapted through different substitutions and substrate recognition mechanisms. This is consistent with the observation that A, C and E employ unique modes of SNAP-25 substrate recognition and cleavage (Vaidyanathan et al. 1999) .
It is puzzling that BoNTs have potentially undergone multiple substrate specificity shifts while retaining the conserved function of SNARE cleavage. Why, for example, have BoNTs not diverged in substrate specificity to cleave one of the thousands of other possible targets in the cell? Determining the events that have contributed to substrate specificity shifts is complicated by the extended contacts between substrates and the light chain, as exosites distant from the active site significantly contribute to binding efficiency, and the importance of different exosites varies among serotypes (Arndt et al. 2005b; Chen, Kim and Barbieri 2007) .
Evolution of the BoNT ancestor
In addition to questions exploring the diversification of BoNT serotypes and subtypes, a fundamental evolutionary question concerns the origin of BoNT itself. It can be reasoned that if the BoNT clade is defined by its neurotoxic function, then the ancestral lineage leading to BoNT is that separating the Weissella and Chryseobacterium toxins from BoNTs (Fig. 1) . Thus, although the first neurotoxic BoNT likely originated within an ancestral Clostridium species, as suggested previously (Collins and East 1998) , earlier BoNT-like ancestors may have existed elsewhere (the phylum Actinobacteria has been suggested as one possible source; Mansfield et al. 2017) .
Although the function of the divergent BoNT-like toxins is still unclear, it is possible that some of them are cytotoxins rather than neurotoxins, and may even target non-neuronal SNAREs as it has been suggested previously (DasGupta 2006) . Interestingly, C. piperi toxin induces kidney cell necrosis and although its target is still unknown, it does not cleave common SNAREs and thus does not appear to be a neurotoxin . Similarly, despite cleaving VAMP2, Weissella BoNT-like toxin has yet to be confirmed as a bona fide neurotoxin and lacks some key features (e.g. disulfide bond separating the LC and HC) that are essential for BoNT-like neurotoxicity.
The features found uniquely in the BoNT clade which are absent in these early diverging lineages are nonetheless of considerable interest, as these may differentiate neurotoxic from cytotoxic activity. By evaluating BoNT features in a phylogenetic context (Fig. 1) , it is possible to infer which features may have been gained in the lineage leading to BoNTs, and may thus have contributed to the evolution of neurotoxicity. These include (but are not limited to) the following:
1. Emergence of the BoNT gene cluster 2. Evolutionary shifts in the 'light chain' protease domain 3. Modification of a pre-existing translocation domain 4. Gain of the LamG-like receptor-binding domain 5. Gain of the SxWY binding motif
Evolutionary origin of the BoNT gene cluster
An important innovation that coincides with the emergence of the BoNT lineage is the appearance of the bont-ntnh synteny and flanking hemagglutinin or ORFX genes. The bont-ntnh synteny is a derived feature of all CNTs except TeNT. It is interesting that the more divergent relatives of BoNTs (Weissella and Chryseobacterium) lack most of the hallmarks of BoNT gene clusters. That is, although the Weissella BoNT-like toxin is located next to a paralog with some similarities to NTNH, there are no HA or ORFX proteins. Similarly, numerous pseudogenes and duplicates are found near the BoNT-like toxin genes in C. piperi, and the immediately neighboring genes are perhaps analogous to NTNH (they possess M27-like protease domains but lack HExxH motifs). However, the surrounding genes and the 'NTNH-like' analogs found in C. piperi do not appear to be direct orthologs of those in BoNTs.
Based on this, it appears that the BoNT ORFX and HA gene clusters evolved in the ancestral BoNT lineage (marked in Fig. 1 ). How did this occur and from where did these associated genes originate? It is quite clear that NTNH is a paralog of BoNT and evolved by a tandem gene duplication followed by divergence (Doxey et al. 2008; Gu et al. 2012) . The origin of the ORFX and HA proteins, however, is more unclear. Bioinformatic analyses have suggested that some of these proteins may be derived from an ancestral toxin gene cluster, since statistically significant sequence similarity was detected between HA proteins and other clostridial toxins (Doxey et al. 2008) . Notably, homology was detected between the HA70 component of BoNT gene clusters and the major virulence factor, CPE, C. perfringens enterotoxin (Doxey et al. 2008) . This prediction has been further supported by the recently solved structure of HA70 (Amatsu et al. 2013 ; PDB ID 3WIN), whose closest structural neighbor in the Protein Data Bank is also CPE (PDB ID 3AM2, P-value = 3.57E-9). The HA33 component of BoNT gene clusters is homologous to ricin type beta-trefoil domains found outside of the BoNT gene cluster (Arndt et al. 2005a; Doxey et al. 2008) , such as Bacillus thuringiensis toxins (e.g. WP 088070506.1) and Lysinibacillus sphaericus mosquitocidal toxin. The ORFX gene clusters also possess intriguing similarities to other toxin gene clusters outside of Clostridium sp., found in species of Paenibacillus, B. thuringiensis and others.
Based on these similarities, the HA and ORFX gene clusters appear to be derived from pre-existing toxin gene clusters that are present in pathogens that are related to Clostridium. It is therefore possible that an ancestral BoNT-like toxin fused together with a pre-existing HA or ORFX gene cluster by recombination and perhaps lateral transfer. Given the phylogenetic distribution of HA and ORFX homologs, it appears that this ancestral gene fusion may have occurred within an ancestral Clostridium species. Further bioinformatic analysis of the distribution of ORFX and HA genes in genomes and metagenomes may shed further light into the origin and evolutionary diversification of the bont gene cluster.
Origin and evolution of the BoNT light chain
The BoNT LC forms a distinct sequence family, and is classified as peptidase family M27 under the 'MA' clan based on MEROPS (Rawlings, Barrett and Finn 2016) . Notably, in addition to the BoNT and TeNT light chains, this clan contains additional protease families, many of which are found in toxins, and include anthrax lethal factor (family M34), bacterial collagenase (M9) and IgA proteases (M26 and M64). Proteases are classified under the MA clan based on a shared catalytic mechanism and gluzincin motif (Xaa-Xbb-Xcc-His-Glu-Xbb-Xbb-His-Xbb-Xdd, where Xaa is hydrophobic or Thr, Xbb is uncharged, Xcc is any amino acid except Pro and Xdd is hydrophobic (Jongeneel, Bouvier and Bairoch 1989) .
Based on these similarities of function and mechanism, it should be expected that the BoNT LC is ultimately derived from another family of MA proteases. Mansfield et al. (2017) recently provided evidence for this evolutionary hypothesis by identifying similarities to peptidase family M91, a family of type III effector peptidases that includes E. coli NleD and also Xanthomonas HopH1. Interestingly, the divergent homologs of BoNTs such as Chryseobacterium toxins possess overlapping peptidase M91 and peptidase M27 annotations. The Pfam database lists M91 as the only domain family with detectable similarity to M27 (see Pfam identifier PF01742), further supporting a link between these families. As shown by Mansfield et al. (2017) , the M91 domain of type III effector proteases shares numerous catalytic features found in BoNT-LC, including not only the HExxH motif but also the third zinc ligand E261, the catalytically important E350 and RxxY motif. There are additional functional similarities between the two families, as both peptidase M91 type III effectors and the BoNT light chain are bacterial protease toxins that cleave intracellular eukaryotic targets.
However, it is the differences between the two that are perhaps more interesting from an evolutionary standpoint. The M91 peptidase type III effector proteins, which consist of a single protease domain, are injected into host cells by the type III secretion system directly, while BoNTs enter cells by receptormediated endocytosis and subsequent translocation into the cytosol by the activity of the heavy chain. M91 proteases are not known to cleave SNAREs, instead cleaving JNK and p38 in host cells (Baruch et al. 2011; Creuzburg et al. 2017) , thereby disrupting the host immune system. Although these substrates are quite different, as are the effects of their cleavage, there is another possible functional similarity: p38 is involved in endosomal fusion and trafficking (Cavalli et al. 2001) . Thus, although the function of the hypothetical M91-LC ancestor is unknown, these commonalities suggest that it may have been involved in disrupting vesicle function.
One of the clear differences between BoNT light chain peptidases and the peptidase M91 family is the presence of two insertion regions, conserved among all BoNTs and present to some extent in BoNT-like proteins. The first insertion is found from residues Phe 282-Leu 345 in BoNT A1, and includes residues that contribute to the SNARE substrate binding pocket. The second is found at the C terminus (Lys 371 to the end of the LC), and changes in these regions have significant effects on toxin activity (Baldwin et al. 2004; Kumaran et al. 2008; Mizanur et al. 2013) . Considering the different substrates of the two peptidase members, it is possible that these insertion regions play a role in the SNARE specificity unique to BoNT LCs, and quite possibly the BoNT-like toxins as well.
The species in which a hypothetical M27-M91 ancestral protease first evolved is also an interesting question, as type III secretion systems are limited to Gram negative organisms, and CNTs are limited to Gram positives. Perhaps the idea put forth by DasGupta (2006) of a viral origin of BoNT provides a partial explanation for the occurrence of BoNT-like genes in such distantly related taxa. At this point, however, the repertoire of BoNT-like genes outside of Clostridium is still too narrow to be able to infer a lineage in which BoNT-like toxins first evolved, and the directionality of the relationship between M27 and M91 proteases (i.e. which came first) is also unclear.
Origin and evolution of the translocation domain
The translocation domain is one of the most puzzling aspects of BoNT function and evolution. Iterative PSI-BLAST searches starting with BoNT translocation domains as queries detect homologous regions in BoNT/X and BoNT/En, as well as the divergent BoNT-like toxins from Weissella and Chryseobacterium. Thus, at least some portion of the translocase domain appears to have been present in the common ancestor prior to the emergence of true BoNTs.
The complexity of the translocation mechanism makes it unlikely that the translocase domain evolved uniquely in the BoNT ancestor. A more likely explanation is the repurposing of pre-existing, functionally similar protein domains, most likely from other toxins. Indeed, homologs of the translocation domain can be found in a large family of putative toxins from entomopathogenic fungi ) (e.g. the region from residues 379 to 513 of NCBI accession # XP 008602550.1). Many of these fungal sequences contain predicted N-terminal ADP-ribosyltransferase domains rather than BoNT-like proteases. Assuming these genes originated from a common source, the large phyletic distance between fungi and bacteria necessitates an ancestral lateral transfer event, although it is difficult to determine the directionality of this transfer. Regardless, these fungal sequences possess translocase-like domains that are more similar to BoNTs than any others in current databases, suggesting that the translocase domain exists outside of the BoNT family alone.
In addition to these entomopathogenic fungal toxins, another possible distant relationship to the translocase domain may be the T domain of diphtheria toxin . Statistically significant sequence similarity between the two can be detected after two PSI-BLAST iterations, and common motifs can be identified which span most of the diphtheria T domain and an N-terminal portion of the BoNT translocase domain. This sequence similarity, and the presence of conserved motifs, is surprising considering the structural differences between the two translocase domains-the diphtheria T domain possesses a different fold than BoNT translocases. However, it is possible that these similarities provide evidence for the 'molten globule' model of BoNT translocation in which translocation involves the unraveling of tertiary structures (Bychkova, Pain and Ptitsyn 1988; van der Goot et al. 1991; Puhar et al. 2004; Kukreja and Singh 2005; Rossetto, Pirazzini and Montecucco 2014) . Thus, it is possible that the detected relationship between the translocase domains of BoNT and DT reflects structural similarities that only become apparent in the molten globule membraneinsertion intermediate state. Importantly, however, if there is a relationship between the BoNT and DT translocases, it only involves the N-terminal portion of the BoNT translocation domain. The C-terminal portion of the BoNT translocation domain, which adopts an extended alpha helical bundle structure, is still of unknown origin.
Evolution of the binding domains
Both of the heavy chain binding domains (the N-terminal binding domain H CN and C-terminal binding domain H CC ) are detectable in all BoNTs, including divergent variants in the Weissella BoNT-like toxin, and thus were likely present early in the BoNT ancestor. In the Chryseobacterium toxins, ricin-type betatrefoil domains can be detected in the C-terminal regions, which may be orthologous to the BoNT H CC domain, although the H CN (LamG) domain is not currently detectable based on sequence similarity or structure prediction approaches (e.g. threading). Thus, it is possible the BoNT ancestor possessed a domain architecture similar to the C. piperi toxins, consisting of a BoNT-like LC and translocase domain, but only part of the receptor binding machinery. This ancestral H CC domain may have targeted different cell surface receptors, which is consistent with the absence of the SxWY motif in the early-diverging BoNT-like lineages (Fig. 1 ). Adaptive evolution of the H CC and gain of the LamG (H CN ) domain may have been key evolutionary innovations that resulted in the emergence of neuron binding in the BoNT ancestor. An ancestral gain of the H CN LamG domain is entirely possible given that the broader LamG domain family is widespread outside of BoNTs; LamG domains homologous to H CN domains are present in non-BoNT proteins including Vibrio MSHA biogenesis protein MshQ (ALM69800), and ALP-like superfamily proteins from Bacillus spp. (WP 071711091.1). The gain of the H CN LamG domain at the base of the BoNT lineage, potentially from other bacterial LamG-domain containing proteins such as these, may have brought with it an increased ability to bind phospholipids on neuronal cell surfaces (Muraro et al. 2009; Zhang et al. 2013) .
The numerous links to insects
One of the recurring themes that appears when analyzing homologs of BoNTs and the other members of the gene cluster is a link to insects. Homologs of ORFX and HA proteins can be found in insecticidal gene clusters; partial homologs of BoNTs can be detected in entomopathogenic fungi; BoNT-like gene fragments have been identified in insect gut metagenomes. Do these links reflect evolutionary similarities to invertebrate-specific BoNTs or BoNT-like toxins? Is it possible that some of the identified BoNTs are already adapted for invertebrate hosts? Or, do these similarities reflect other roles that insects play in the BoNT life cycle?
What is the ecological function of BoNT in environmental clostridia?
One last fundamental question about the origin of BoNT concerns not the evolution of its molecular function, but rather the adaptive value it provides for the bacterium in its natural environment (Montecucco and Rasotto 2015) . It has been hypothesized that BoNT operates as a method for the spread of the pathogen through rapid killing of vertebrate hosts, as is commonly seen in cases of avian botulism. As described by Rossetto, Pirazzini and Montecucco (2014) , botulism in the wild is propagated through a life cycle involving vertebrate decomposition and invertebrate predation. BoNT-producing clostridia are ingested or enter wounds, kill the animal, the animal carrying C. botulinum spores is decomposed by other organisms such as necrophagous fly larvae, which pick up the spores, intoxicate additional animals (e.g. birds) when they are ingested, and the cycle continues. However, there is still one unanswered question regarding the role of BoNTs in this life cycle-what is the adaptive value of neuroparalysis? After all, there are many possible toxin modes of action that could kill an organism, so what is the ecological value of paralyzing the host with such extreme specificity?
According to forensic entomology, animal decomposition takes on a predictable succession of stages: fresh, bloat, active decay, advanced decay and dry decay, and each stage is associated with specific arthropod species that have adapted to that stage to efficiently use resources and proliferate (Payne 1965; Joseph et al. 2011) . How might BoNT-induced paralysis influence a decomposition cycle such as this in the wild? By paralyzing the host, C. botulinum may effectively favor certain species of necrophagous invertebrates such as blowflies, effectively 'freezing' the host before later stages of decomposition occur. A paralyzed host would provide fresh tissue before later stages of decomposition are initiated by the microbial necrobiome (anaerobic bacteria, fungi), and thus a major competitive advantage to these early-stage necrophagous insects, especially if they are also the vectors of C. botulinum spores. It is tempting to speculate that BoNTs may therefore have originally evolved due to competition between scavengers in decomposition. It is also conceivable that some BoNTs may have evolved broader host specificity to target not only the host vertebrate but also target competing necrophagous invertebrates.
Members of the Calliphoridae are known to harbor C. botulinum spores, lending credence to the idea of a link to necrophagous insects (Hubálek and Halouzka 1991; Anza, Vidal and Mateo 2014) . The exact nature of the relationship of BoNTs to insects and decomposition, however, remains to be seen. It is also important to note that there is not one but potentially many ecological cycles that involve different BoNT-producing taxa and different hosts.
With this in mind, it is tempting to speculate that the divergent BoNT-like toxins from Chryseobacterium, Weissella and Enterococcus could be part of similar ecological cycles in the wild but with different host organisms than those typically studied in the context of bacterial pathogenesis. Alternatively, it is also possible that these BoNT-like toxins reflect remnants of earlier cytotoxin lineages that predate the evolution of BoNT and its neuroparalytic role in decomposition. Future studies that examine the ecological life cycle of C. botulinum in the wild, and evaluate the fitness impact of BoNT on C. botulinum, its vectors and the broader 'necrobiome' community will likely shed light on these important questions.
CONCLUSIONS
Traditionally, BoNTs have been defined based on their neuroparalytic activity and their occurrence in C. botulinum and related species. In the post-genomic era that has generated over a hundred thousand bacterial genomes, it is still true that bona fide BoNTs exist predominantly within Clostridium, perhaps with the exception of the recently identified BoNT from En. faecium (BoNT/En). However, BoNT-like toxins with divergent activities exist outside of the Clostridium genus and may be remnants of a much older lineage of toxins. Several key features differentiate BoNTs from BoNT-like toxins and likely played a role in their evolution, including acquisition of NAPs, substrate specificity changes in an ancestral LC, extension/modification of the translocation domain, gain of the H CN binding domain and adaptive changes in binding specificity within the H CC domain. The precise order that these evolutionary events occurred, all of which may have affected the function of the ancestral toxin, is for the moment difficult to discern. All of the BoNT domain families appear to have existed in some form within the ancestral precursor to the BoNT lineage. Thus, it is conceivable that a three or four-domain BoNT-like cytotoxin existed in an ancient species (Clostridium or elsewhere) which targeted non-neuronal SNAREs, and subsequently adapted to become a neurotoxin.
Assuming that BoNTs have functionally differentiated from precursors that were already toxins, their true adaptive benefit likely relates to their neuroparalytic effect on the host. To understand this adaptive role, it is important to examine in detail the role of BoNTs in its ecological life cycle. We suggest that this role may be to delay the occurrence of decomposition to provide a competitive advantage to necrophagous invertebrates that are specialized for early stages, which in turn benefit toxigenic C. botulinum by facilitating its dispersal.
METHODS

Data sources
A dataset representing known BoNT subtype amino acid sequences was collected, a list of which is available from Peck et al. (2017) , with the addition of BoNT/X, BoNT/En and the BoNT-like sequences from Weissella (NCBI accession number WP 027699549.1) and Chryseobacterium (WP 034687872.1). A list of accession numbers used is available in Table S1 (Supporting Information).
Phylogenetic analysis
Full-length BoNT sequences were aligned using Clustal Omega version 1.2.1 (Sievers et al. 2011 ) with default parameters.
A maximum-likelihood BoNT phylogeny was generated using RAxML version 8.2.4 (Stamatakis 2014) with automatic substitution model selection and gamma-distributed rate heterogeneity, with 1000 rapid bootstraps. For Fig. 1 , the tree was midpoint rooted and visualized using Figtree (available from http://tree.bio.ed.ac.uk/software/figtree/). The features mapped on the tree were determined from a number of sources, available in Table S1 (Supporting Information).
